Other Planned Studies: AS-MQ in India [and] Asia.


This presentation describes two proposed studies of artemisinin-based combination therapies against uncomplicated Plasmodium falciparum malaria: one in India, to assess the efficacy, safety and population pharmacokinetics of ASMQ (fixed dose artesunate + mefloquine), and one in Myanmar (Burma), to compare the effectiveness of the current first-line treatment (artesunate and mefloquine as separate loose tablets) with 4 alternatives: ASMQ, artemether-lumefantrine, dihydroartemisinine-piperaquine, and ASAQ (fixed dose artesunate + amodiaquine).


Presentatation from: Scientific Symposium "Implementation of Artemisinin Combination Therapies (ACTs): Role of ASMQ". Rio de Janeiro, Brazil, 17 April 2008.

Other Planned Studies: AS-MQ in India [and] Asia.

Published 1 January 2008